I. INTRODUCTION

Stroke has increasingly become a critical global health challenge and stands as one of the primary causes of both morbidity and mortality, particularly among individuals with cardiovascular conditions[^1]. The intricate relationship between cardiovascular diseases and the heightened risk of stroke is firmly established in the scientific literature. Numerous epidemiological studies have demonstrated that patients suffering from cardiovascular disorders are significantly more prone to experience stroke when compared to those without any cardiovascular issues. Among the array of heart diseases, atrial fibrillation, coronary artery disease, and heart failure are recognized as the most prevalent conditions that contribute to the underlying mechanisms leading to stroke^2,3.

The effective prevention and treatment of stroke significantly depend on precise risk assessment, which necessitates the identification of robust and reliable predictive indicators[^4]. A deep understanding of these indicators is vital for healthcare providers as it enables the implementation of timely and targeted interventions, ultimately aimed at reducing stroke incidence among atrisk cardiac patients. Clinical factors are crucial in this risk stratification process; demographic characteristics (age, gender, ethnicity), detailed medical history, and related comorbidities must all be considered. In addition to clinical assessments, biochemical markers such as hypertension readings, lipid profiles, and inflammatory markers including C-reactive protein and Interleukin-6—have been closely associated with an elevated risk of stroke ${}^{5-8}$.

Further enhancing the ability to predict stroke is the adoption of advanced imaging technologies, which allow for the detailed visualization of anatomical abnormalities that may predispose patients to thromboembolic events. Techniques like carotid ultrasound and transesophageal echocardiography can reveal significant structural issues that are not always apparent through standard clinical evaluations alone[^9].

This study aims to comprehensively investigate the various indicators that predict stroke risk in patients with cardiovascular diseases by meticulously evaluating clinical, biochemical, and imaging factors. By synthesizing existing research and conducting a robust retrospective analysis of patient data over a defined period, the study seeks to elucidate the complex interactions between these indicators and their cumulative impact on stroke risk. Ultimately, the intention of this research is to provide healthcare professionals with a more precise and clearer framework for identifying patients at elevated risk, thereby enabling the development of more effective prevention strategies and leading to improved patient outcomes. Understanding the multifaceted interplay between heart disease and stroke is imperative, as such knowledge will contribute to more accurate risk classification and the formulation of targeted preventive measures[^10].

II. METHODOLOGY

a) Study Design

This research employed a comprehensive retrospective cohort design aimed at identifying stroke prediction indicators among patients with cardiovascular diseases. The study encompassed a diverse group of patients treated at a tertiary care hospital from January 2020 to December 2022. Ethical considerations were paramount; thus, the study protocol received approval from the institutional review board to ensure the protection of patient rights and confidentiality throughout the research process.

b) Study Population^9,10

The study population consisted of 200 patients diagnosed with various cardiovascular conditions, with a mean age of 65 years, reflecting a geriatric predisposition commonly seen in cardiovascular disease. Inclusion criteria for the cohort were strictly defined, encompassing patients with confirmed diagnoses of coronary artery disease (CAD), heart failure, or atrial fibrillation (AF). Patients were required to have established medical records and recent evaluations to ensure accurate data collection. Notably, those with a documented history of stroke prior to enrollment were rigorously excluded from the analysis to prevent confounding variables that could skew the study results. This careful selection aimed to create a clear focus on the relationship between existing cardiovascular diseases and their role in stroke risk.

c) Data Collection

Data collection was conducted meticulously, leveraging the hospital's medical records. Clinical information gathered included demographic variables such as age, gender, and ethnicity, as well as detailed medical histories that included previous cardiovascular events and comorbid conditions influencing stroke risk. Risk factor assessments incorporated essential clinical parameters such as blood pressure measurements, which were taken at multiple points to ensure accuracy, and lipid profiles that provided insights into the cholesterol levels of patients ${}^{11}$.

Biochemical markers were a key focus of the study; inflammatory markers, particularly C-reactive protein and Interleukin-6, were carefully measured to assess their correlation with heightened stroke risk. This biochemical analysis was performed using established laboratory protocols to ensure reliability and reproducibility of results ${}^{12}$.

In addition to clinical and biochemical data, advanced imaging modalities were utilized to enhance stroke risk assessment ${}^{13}$. Imaging studies such as carotid ultrasound and transesophageal echocardiography were employed to identify any structural abnormalities in the heart and blood vessels, which might predispose patients to thromboembolic events ${}^{14}$. These imaging results were crucial in differentiating patients with significant anatomical risk factors from those without observable issues ${}^{15,16}$.

By integrating clinical, biochemical, and imaging data, this study aimed to create a robust risk profiling framework, ultimately enhancing the understanding of stroke predictors in the cardiac patient cohort.

d) Statistical Analysis

Data were analyzed using SPSS software. Descriptive statistics were calculated for baseline characteristics. Logistic regression models were employed to assess the association between potential stroke indicators and the incidence of stroke, adjusting for confounding variables.

III. RESULTS

a) Participant Characteristics

The cohort comprised 200 patients, with $58\mathrm{\%}$ male and $42\mathrm{\%}$ female. The prevalence of conditions was as follows: CAD $(40\mathrm{\%})$, heart failure $(30\mathrm{\%})$, and AF $(30\mathrm{\%})$. The average follow-up duration was 24 months, during which 45 patients $(9\mathrm{\%})$ experienced a stroke.

Table

b) Clinical Indicators

c) Biochemical Indicators

d) Inflammatory Markers

e) Imaging Indicators

IV. DISCUSSION

The findings from this study underscore the critical interplay between various cardiovascular conditions and the heightened risk of stroke among cardiac patients. The retrospective analysis involving 200 patients has revealed significant associations of atrial fibrillation (AF), coronary artery disease (CAD), heart failure, hypertension, and dyslipidemia with increased stroke incidence. These results align with existing literature that suggests patients with underlying cardiovascular issues face a notably higher risk of experiencing a stroke compared to the general population ${}^{14}$.

Atrial fibrillation emerged as a prominent risk factor in our study, corroborating previous research that has consistently highlighted its role in thromboembolic events. AF increases the likelihood of blood clots forming in the heart, which can subsequently lead to ischemic strokes. Therefore, early identification and management of AF in at-risk populations are paramount. Similarly, coronary artery disease and heart failure were closely linked with elevated stroke risk. The pathophysiological mechanisms underlying these conditions often involve reduced cardiac output and impaired blood flow, both of which can contribute to the conditions conducive to stroke occurrence.

Hypertension and dyslipidemia were also identified as critical risk factors, reinforcing their recognized roles in cardiovascular health. The combination of elevated blood pressure and abnormal lipid levels can accelerate atherosclerosis, leading to plaque build-up in arteries, which in turn can obstruct blood flow and provoke stroke ${}^{15}$. This highlights the importance of regular monitoring and management of these risk factors within the cardiac patient population.

Furthermore, the incorporation of biochemical markers and advanced imaging techniques in our study provided a comprehensive approach to stroke risk assessment. The measurement of inflammatory markers such as C-reactive protein and Interleukin-6, known to be associated with systemic inflammation, offered additional insight into cardiovascular health and potential stroke risk. Similarly, imaging modalities like carotid ultrasound allowed for the identification of anatomical abnormalities that might predispose patients to thromboembolic events, which may not be evident through standard clinical assessments alone ${}^{16,17}$.

This study's results contribute significantly to the existing body of knowledge regarding stroke risk stratification in cardiac patients. By identifying and evaluating these predictive indicators, healthcare providers can better understand the complexities of stroke risk within this vulnerable population. Ultimately, the findings advocate for a multidimensional approach to risk assessment that encompasses clinical evaluation, biochemical analysis, and advanced imaging ${}^{18}$.

In conclusion, effective stroke prevention in cardiac patients relies heavily on the ability to identify those at heightened risk through a thorough understanding of associated indicators. The insights garnered from this research may facilitate the development of targeted prevention strategies, enabling healthcare professionals to implement timely and appropriate interventions aimed at reducing stroke incidence and improving overall patient outcomes in the cardiac population. Future studies should aim to further refine these indicators and explore additional factors that may influence stroke risk to enhance the predictive capabilities for healthcare providers.

V. CONCLUSION

The findings highlight the need for thorough risk assessments in cardiac patients to implement timely stroke prevention strategies. Integrating clinical data, biochemical markers, and advanced imaging techniques allows healthcare professionals to more effectively identify at-risk individuals.

By enhancing our understanding of the interplay between cardiovascular diseases and stroke risk, this research equips healthcare providers with insights to refine patient management strategies. The ultimate goal is to reduce stroke incidence and improve outcomes for cardiovascular patients through targeted interventions. Future studies should further validate these findings and explore the connections between cardiovascular diseases and stroke risk.

Analyzing key clinical, biochemical, and imaging markers is crucial for estimating stroke risk in cardiac patients. By incorporating these indicators into standard clinical practice, healthcare professionals can enhance risk stratification and identify effective preventive interventions. This approach will ultimately help reduce the burden of stroke among this vulnerable group.

• stroke and high risk of stroke: The need for interdisciplinary action: A consensus report from the European Society of Cardiology Cardiovascular Round Table. Eur J PrevCardiol. 2020 May; 27(7):682-692. doi: 10.1177/20474873198734 60. Epub 2019 Sep 30. Erratum in: Eur J PrevCardiol. 2020 Aug; 27(12):NP1. doi: 10.1177/2047487320 940615. PMID: 31569966; PMCID: PMC7227126.

1. Yang Y, Zheng J, Du Z, Li Y, Cai Y, Accurate Prediction of Stroke for Hypertensive Patients Based on Medical Big Data and Machine Learning Algorithms: Retrospective Study, JMIR Med Inform 2021;9(11):e30277

2. Jan Jakub Kęsik, Wiesław Paja, Piotr Terlecki, Marek Ilżecki, BartoszKlebowski, Joanna Depciuch, Raman spectroscopy combined with machine learning and chemometrics analyses as a tool for identification atherosclerotic carotid stenosis from serum, SpectrochimicaActa Part A: Molecular and Biomolecular Spectroscopy, 326, (125198), (2025). https://doi.org/10.1016/j.saa.2024.125198

3. Evelyn B Voura, Tabatha M Jorgensen, John R Stulb, Margaret E Mulligan, David J Padalino, A Retrospective Analysis of the Underlying Health Status of Patients Treated for Stroke in the Emergency Department of a Community Hospital Situated in a Health Professional Shortage Area, Cureus, (2024). https://doi.org/10.7759/cureus.68150

4. Vedant N Hedau, TusharPatil, Mounting Stroke Crisis in India: A Systematic Review, Cureus, (2024). https://doi.org/10.7759/cureus.57058

5. DilcanKotan, GüvenAkçay, Motor and Cognitive Function Impairment as a Result of Haemorrhagic Stroke in a Hypertensive Patient: A Case Study, Recent Trends in Pharmacology, 2, 2, (83-87), (2024). https://doi.org/10.62425/rtpharma.1441977

6. Alanazi E, Abdou A, Luo J, Predicting Risk of Stroke From Lab Tests Using Machine Learning Algorithms: Development and Evaluation of Prediction Models, JMIR Form Res 2021;5(12):e23440

7. Li X, Tao S, Jamal- Omidi S, Huang Y, Lhatoo SD, Zhang G, et al. Detection of postictal generalized electro encephalogram suppression: Random forest approach. JMIR Med Inform 2020 Feb 14;8(2):e17061

8. Kim M, Jee SH, Yun JE, Baek SJ, Lee D. Hemoglobin concentration and risk of cardiovascular disease in Korean men and women - The Korean Heart Study. J Korean Med Sci 2013 Sep; 28(9):1316-1322

9. Chen, CH., Huang, PW., Tang, SC. et al. Complexity of Heart Rate Variability Can Predict Stroke-In-Evolution in Acute Ischemic Stroke Patients. Sci Rep 5, 17552 (2015).

10. Podell, J., Pergakis, M., Yang, S. et al. Leveraging Continuous Vital Sign Measurements for Real-Time

• Assessment of Autonomic Nervous System Dysfunction After Brain Injury: A Narrative Review of Current and Future Applications. Neurocrit Care 37 (Suppl 2), 206-219 (2022)

1. Lucci VM, Inskip JA, McGrath MS, Ruiz I, Lee R, Kwon BK, et al. Longitudinal assessment of autonomic function during the acute phase of spinal cord injury: use of low-frequency blood pressure variability as a quantitative measure of autonomic function. J Neurotrauma. 2021; 38:309-21.

2. Brinza C, Floria M, Covic A, Burlacu A. Measuring heart rate variability in patients admitted with stroke elevation myocardial infarction for the prediction of subsequent cardiovascular events: a systematic review. Medicina (Kaunas). 2021; 57:1021.

3. Aakanshi Gupta, Nidhi Mishra, NishthaJatana, Shaily Malik, Khaled A. Gepreel, FarwaAsmat, SachiNandanMohanty, Predicting stroke risk: An effective stroke prediction model based on neural networks, Journal of Neurorestoratology, 2024,100-156, ISSN 2324-2426

4. Z.H. Zhang, M.W. Beck, D.A. Winkler, et al, Opening the black box of neural networks: methods for interpreting neural network models in clinical applications Ann Transl Med, 6 (11) (2018), p. 216, 10.21037/atm.2018.05.32

5. Hassan, A., Gulzar Ahmad, S., UllahMunir, E. et al. Predictive modelling and identification of key risk factors for stroke using machine learning. Sci Rep 14, 11498 (2024). https://doi.org/10.1038/s41598-024-61665-4

6. Bersano, A. & Gatti, L. Pathophysiology and treatment of stroke: Present status and future perspectives. Int. J. Mol. Sci. 24, 14848 (2023).

7. K Reshma, Merlin Shalini Ruth, Indian J Anaesth, 2023 Feb; 67(2):226-227. doi: 10.4103/ija. ija 864 21. Epub 2023 Feb 16.

8. Qin C, Murali S, Lee E, Supramaniam V, Hausenloy DJ, Obungoloch J, Brecher J, Lin R, Ding H, Akudjedu TN, Anazodo UC, Jagannathan NR, Ntusi NAB, Simonetti OP, Campbell-Washburn AE, Niendorf T, Mammen R, Adeleke S. Sustainable lowfield cardiovascular magnetic resonance in changing healthcare systems. Eur Heart J Cardiovasc Imaging. 2022 Jun 1;23(6):e246-e260. doi: 10.1093/ehjci/jeab286. PMID: 35157038; PMCID: PMC9159744.